Regeneron Pharmaceuticals, Inc.

A medial security in the Health Care that looks (login to see)

Yahoo! Profile

REGN

Pharmaceutical Preparation Manufacturing
Weighting

Balanced Growth

Lead | Lag

Medial

Options

n/a

P/E Ratio

31.42

Free Cash Flow

Positive (0.31)

Dividend

none

Begin Today!

Have access to custom plans you can create, auto-portfolios and much more!




NO OBLIGATION TO BUY